Limited Benefit of Additional Chartis® Assessments for Collateral Ventilation Evaluation in Patients with Software Quantified Intact Target Lobe Fissure – Results from a Retrospective Analysis of the German Lung Emphysema Registry
This analysis did not find evidence that a Chartis<sup>®</sup> assessment provided additional benefit to the treatment response after ELVR at 3-month follow-up in patients with an intact fissure of the target lobe with an FCS ≥95%. These findings may be clinically relevant as they suggest that additional invasive Chartis<sup>®</sup> measurement might be dispensable in this subgroup.
Authors
- Ralf‐Harto Hübner (ORCID: https://orcid.org/0000-0001-5969-2089)
- Stephan Eisenmann (ORCID: https://orcid.org/0000-0002-0387-0760)
- Konrad Neumann (ORCID: https://orcid.org/0000-0001-9482-0971)
- Wolfgang Gesierich (ORCID: https://orcid.org/0000-0001-6707-6358)
- Thomas Sgarbossa (ORCID: https://orcid.org/0009-0005-3393-8665)
- Stefan Andreas (ORCID: https://orcid.org/0000-0003-3918-6909)
- Jacopo Saccomanno (ORCID: https://orcid.org/0009-0005-0188-7541)
- Martin Witzenrath
- Franz Stanzel
- Bernd Schmidt (ORCID: https://orcid.org/0000-0002-3358-4116)
Institutions
- Humboldt-Universität zu Berlin (DE)
- Zimmer Biomet (Germany) (DE)
- Asklepios Fachkliniken München-Gauting (DE)
- German Center for Lung Research (DE)
- DRK Kliniken Berlin (DE)
- Lungenklinik Hemer (DE)
- University Hospital in Halle (DE)
- Charité - Universitätsmedizin Berlin (DE)
Publication Details
- Journal
- International Journal of COPD
- Published
- 2025-12-01
- DOI
- https://doi.org/10.2147/copd.s538587
- Primary Topic
- Pleural and Pulmonary Diseases
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Berlin Institute of Health